Krystal Biotech, Inc. ($KRYS)
Filing Information
| Accession Number | 0001209059-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 24, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
56,850
Total Value
$5,120,264.65
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 19, 2026 | Exercise/Conversion | 18,950 | $8.79 | $166,570.50 | 97,641 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 19, 2026 | Sale | 8,116 | $260.49 | $2,114,102.75 | 89,525 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 19, 2026 | Sale | 10,834 | $262.10 | $2,839,591.40 | 78,691 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 19, 2026 | Exercise/Conversion | 18,950 | $0.00 | $0.00 | 0 | Direct | โ | View Details |